Literature DB >> 19758944

Rapid ventricular pacing can reduce heart motion and facilitate stent deployment to the optimal position during coronary artery stenting: initial experience.

Atsunori Okamura1, Hiroshi Ito, Katsuomi Iwakura, Shigeo Kawano, Toshiya Kurotobi, Yasushi Koyama, Motoo Date, Koichi Inoue, Toshio Ogihara, Kenshi Fujii.   

Abstract

AIMS: We have sometimes encountered difficulty in stent positioning, and managed to achieve optimal positioning of the stent by luck when there was extensive movement of the stent delivery system in association with the cardiac cycle. We assessed the safety and efficacy of rapid ventricular pacing in order to achieve precise positioning of the stent in this percutaneous coronary intervention (PCI) situation. METHODS AND
RESULTS: Among 363 patients who underwent PCI, difficulty in positioning of the stent was encountered in 7 consecutive patients due to extensive movement of the stent delivery system. We applied rapid ventricular pacing in these 7 patients. We measured the length of motion of the stent delivery system relative to the coronary artery and systolic blood pressure before and under rapid ventricular pacing at a rate of 160 min-1. The extent of motion was markedly reduced by rapid ventricular pacing (7.3+/-2.6 mm to 1.7+/-0.6 mm; p<0.001). Systolic blood pressure was decreased slightly by rapid ventricular pacing (116+/-15 mmHg to 90+/-7 mmHg; p=0.002), but there were no cases of haemodynamic degeneration or ventricular arrhythmia.
CONCLUSIONS: Rapid ventricular pacing is a safe and promising option for precise stent positioning, when movement of the stent delivery system prevents precise deployment.

Entities:  

Year:  2007        PMID: 19758944     DOI: 10.4244/eijv3i2a41

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  1 in total

1.  First-in-Human Evaluation of the Safety and Efficacy of a Novel Stent Positioning Assistance System for Precise Positioning of Coronary Stents.

Authors:  Elias Hellou; Michael Jonas; Danny Dvir
Journal:  J Interv Cardiol       Date:  2022-03-27       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.